BIO

Bio Rad Laboratories Stock Analysis

AI Rating

Good
  • Quality3/10
  • Growth↑ 9/10
  • Value↓ 3/10
Bio Rad Laboratories sales and earnings growth
BIO Growth
Great
  • Revenue Y/Y↑ 5.77%
  • EPS Y/Y↑ 107.66%
  • FCF Y/Y↓ 0.51%
Bio Rad Laboratories gross and profit margin trends
BIO Profitability
Neutral
  • Gross margin ↑ 51.90%
  • EPS margin↓ 6.50%
  • ROIC 5Y↓ -6.53%
Bio Rad Laboratories net debt vs free cash flow
BIO Risk
Great
  • Debt / Equity↓ 0.2
  • Debt / FCF↓ 2.4
  • Interest coverage↑ 5.5

Bio Rad Laboratories stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Medical Devices stocks